Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2013

Accrued Liabilities abstract

Schedule of accrued expenses

	September 30,		December 31,
	2013		2012
		(unaudited)
Accrued clinical trial and clinical supply costs	$	1,313	$	3,335
Accrued compensation		3,921		2,492
Accrued sales and marketing expenses		1,166		1,315
Accrued interest		2,813		213
Other accrued liabilities		2,905		505
	$	12,118	$	7,860